Substance / Medication

Atropine sulfate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

12 trials linked to this intervention

12
Total Trials
3
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy.
Dias Bruno L Scofano, Fernandes Alexandre R, Maia Heber de S · Arq Neuropsiquiatr · 2017
PMID: 28591387RCT
Objective evaluation of the systemic effects of topical application of 1% atropine sulfate ophthalmic solution in healthy horses.
Wehrman Rita F, Gemensky-Metzler Anne J, Zibura Ashley E et al. · J Am Vet Med Assoc · 2017
PMID: 29154707RCT
The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.
Mubaslat Omar, Lambert Tim · Psychopharmacology (Berl) · 2020
PMID: 32876732Observational
Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study.
Wakayama Akemi, Nishina Sachiko, Miki Atsushi et al. · Jpn J Ophthalmol · 2018
PMID: 30046935Observational
Comparison of the effects of topical and systemic atropine sulfate on intraocular pressure and pupil diameter in the normal canine eye.
Kovalcuka Liga, Birgele Edite, Bandere Dace et al. · Vet Ophthalmol · 2015
PMID: 24428364Observational
Systemic delivery of atropine sulfate by the MicroDose Dry-Powder Inhaler.
Corcoran T E, Venkataramanan R, Hoffman R M et al. · J Aerosol Med Pulm Drug Deliv · 2013
PMID: 22691110ObservationalFull text (PMC)
Prevention of bradycardia by atropine sulfate during urological laparoscopic surgery: a randomized controlled trial.
Aghamohammadi Homayun, Mehrabi Sadrollah, Mohammad Ali Beigi Faramarz · Urol J · 2009
PMID: 19472126Observational
Impurity profiling of atropine sulfate by microemulsion electrokinetic chromatography.
Bitar Yaser, Holzgrabe Ulrike · J Pharm Biomed Anal · 2007
PMID: 16971086Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Atropine sulfate (substance)
SNOMED CT
74237004
UMLS CUI
C0596005

Clinical Data

This intervention maps to 7 entities in the Healos knowledge graph.

7
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
12
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.